Capstone Asset Management’s Boston Scientific BSX Stock Holding History

Capstone Asset Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$4.22M	Sell	152,383 -2,254	-1%	-$59.8K	0.12%	208
2017 Q1	$3.85M	Sell	154,637 -610	-0.4%	-$14.8K	0.11%	224
2016 Q4	$3.36M	Buy	155,247 +415	+0.3%	+$9.05K	0.1%	252
2016 Q3	$3.69M	Buy	154,832 +9,054	+6%	+$216K	0.11%	231
2016 Q2	$3.41M	Buy	145,778 +12,965	+10%	+$280K	0.1%	229
2016 Q1	$2.5M	Sell	132,813 -4,318	-3%	-$75.8K	0.07%	330
2015 Q4	$2.53M	Buy	137,131 +35,605	+35%	+$638K	0.07%	318
2015 Q3	$1.67M	Buy	101,526 +811	+0.8%	+$13.9K	0.05%	414
2015 Q2	$1.78M	Buy	100,715 +11,830	+13%	+$211K	0.05%	410
2015 Q1	$1.58M	Buy	88,885 +2,690	+3%	+$42.5K	0.04%	476
2014 Q4	$1.14M	Sell	86,195 -22,902	-21%	-$293K	0.03%	576
2014 Q3	$1.29M	Buy	109,097 +940	+0.9%	+$11.8K	0.04%	473
2014 Q2	$1.38M	Sell	108,157 -25,758	-19%	-$335K	0.04%	468
2014 Q1	$1.81M	Sell	133,915 -22,480	-14%	-$295K	0.06%	391
2013 Q4	$1.88M	Sell	156,395 -70,780	-31%	-$836K	0.05%	395
2013 Q3	$2.67M	Sell	227,175 -7,150	-3%	-$77.3K	0.06%	353
2013 Q2	$2.17M	Buy	+234,325	New	+$1.99M	0.06%	384

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Capstone Asset Management's BSX Position: Q2 2017 in Review

Capstone Asset Management reduced its Boston Scientific (BSX) stake by 1.5% in Q2 2017, selling an estimated $59.8K and leaving 152,383 shares worth $4.22M. The position accounts for 0.12% of the portfolio, ranked #208.

Capstone Asset Management first reported a position in BSX in Q2 2013 and has held it in 17 quarters since. 558 funds tracked by Wall St. Rank hold BSX as of Q2 2017.

Capstone Asset Management held 152,383 shares of Boston Scientific worth $4.22M as of Q2 2017.
Capstone Asset Management sold 2,254 Boston Scientific shares in Q2 2017, an estimated $59.8K.
Boston Scientific made up 0.12% of Capstone Asset Management's portfolio in Q2 2017, its #208 holding.
Capstone Asset Management first reported a position in Boston Scientific in Q2 2013 and has held it in 17 quarters since.
558 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2017.

Based on Capstone Asset Management's 13F filing for Q2 2017, filed 10 Jul 2017.